Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders
European Journal of Haematology · 2023
DOI: 10.1111/ejh.14079 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2023. Verfasst von Antoine Babuty und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, CHU Nantes, Service d'Hématologie Biologique, Nantes, France. Hauptthemen laut MEDLINE: Blood Platelet Disorders, Hemorrhage, Prothrombin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background
The bleeding risk of patients with mild platelet function disorders is difficult to assess and their phenotype remains ill‐explored.
Aim
This study was designed to establish a comprehensive biological phenotype of patients with mild platelet function disorders.
Methods
Twenty patients were included with persistent abnormal light transmission aggregometry (LTA). The ISTH bleeding assessment tool (ISTH‐BAT) was assessed to identify laboratory analyses associated with an abnormal hemorrhagic score.
Results
The majority of patients had defects that might affect Gαi protein signaling pathways or minor abnormalities. No LTA nor flow cytometry parameters were associated with an above‐normal hemorrhagic score. However, prothrombin consumption, which corresponds to the ratio of serum residual factor II to plasma residual factor II, was significantly higher ( p = .006) in the abnormal ISTH‐BAT group (mean = 14%, SD = 6) compared with the normal ISTH‐BAT group (mean = 8%, SD 4). Prothrombin consumption was significantly associated with ISTH‐BAT score ( r = .5287, IC 95% 0.0986–0.7924, p = .0165).
Conclusion
In this group of patients, there was an association between a pathological bleeding score and increased prothrombin consumption. This test could be used as an additional indicator of platelet function abnormality liable to be related to bleeding risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nantes Université, CHU Nantes, Service d'Hématologie Biologique, Nantes, France.
- Nantes Université, CHU Nantes, Centre de Ressource et de Compétence-Maladies Hémorragiques Constitutionnelles, Nantes, France.
ORCID-Profile: Antoine Babuty, Camille Debord, Nicolas Drillaud, Marion Eveillard, Marc Trossaert, Marianne Sigaud, Marie C Béné, Marc Fouassier
Zitieren
APA
Babuty, A., Debord, C., Drillaud, N., Eveillard, M., Trossaert, M., Ternisien, C., Sigaud, M., Cador, E., Béné, M. C., & Fouassier, M. (2023). Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders. European Journal of Haematology. https://doi.org/10.1111/ejh.14079
Vancouver
Babuty A, Debord C, Drillaud N, Eveillard M, Trossaert M, Ternisien C, et al. Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders. European Journal of Haematology. 2023. doi:10.1111/ejh.14079
BibTeX
@article{Babuty2023,
author = {Babuty, Antoine and Debord, Camille and Drillaud, Nicolas and Eveillard, Marion and Trossaert, Marc and Ternisien, Catherine and Sigaud, Marianne and Cador, Emmanuelle and Béné, Marie C and Fouassier, Marc},
title = {Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders},
journal = {European Journal of Haematology},
year = {2023},
doi = {10.1111/ejh.14079}
}
EUVIMED